Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model
published in: Archives of Gynecology and Obstetrics
date of publication: 2020-11-02
main subject: ovarian hyperstimulation syndrome
Cites articles
There is nothing here
Article - wd:Q101210802